Clinical Trial Update: Anti-CD19 CAR-T Therapy Combine With HSCT to Treat MRD+ B-cell Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes an anti-CD19 CAR-T therapy combined with hematopoietic stem cell transplantation for MRD-positive B-cell malignancies, in Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Lymphoma

Drugs mentioned

• Anti-CD19 CAR-T therapy (CAR-T cell therapy targeting CD19)
• Hematopoietic stem cell transplantation

Snippet

Sponsor: Wuhan Sian Medical Technology Co., Ltd | Conditions: Acute Lymphoblastic Leukemia, B Cell Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN